Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Lu Lu|Cell Research|2020Cited by 1.4k
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 OmicronHuiping Shuai, Hin Chu, Bao‐Zhong Zhang et al.|RePEc: Research Papers in Economics|0Cited by 647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitorLu Lu, Shibo Jiang, Qi Liu et al.|Nature Communications|2014Cited by 400
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamstersShuofeng Yuan, Jasper Fuk‐Woo Chan, Zi‐Wei Ye et al.|Science|2022Cited by 222
A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetusesYufeng Yu, Lu Lu, Yong‐Qiang Deng et al.|Nature Communications|2017Cited by 151